Company attributes
Location
B2X
Founder
AngelList URL
Pitchbook URL
Date Incorporated
2006
Number of Employees (Ranges)
11 – 50
Phone Number
+33141506204
Number of Employees
30
Full Address
20 Boulevard Bénoni Goullin 44200 Nantes France
Founded Date
2006
Total Funding Amount (USD)
27,307,000
Latest Funding Round Date
January 15, 2018
Competitors
Stock Symbol
ALPHE
Latest Funding Type
Patents Assigned (Count)
5
Wellfound ID
Country
Other attributes
Company Operating Status
Active
Pherecydes Pharma is a biotechnology company developing phage therapies for fighting bacterial infections that is headquartered in Romainville, France and was founded in 2006 by Jerome Gabard and Manuel Gea.
Funding
Series A
On December 1, 2014 Pherecydes Pharma completed their series A funding round with €1.9 million in funding from Auriga Partners.
Series B
On January 16, 2018 Pherecydes Pharma completed their series A funding round with €8.7 million in funding from Go Capital (lead investor), Omnes Capital, FaDiese, Auriga Partners, and ACE Management.
Timeline
No Timeline data yet.
